Targeted & controlled bone healing

Analysts

Mirabaud Securities Ltd
Olav Zilian, MD, PhD, EMBA

Laura Pfeiffer-Rossi
Octavian AG

NIBC Bank N.V.
Dylan van Haaften

LifeSci Capital
David Sherman, Ph.D.(AC)
REPORTS ENGLISH GERMAN
LifeSci Capital - Initiation Research  
Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Analysts
  5. Calendar
  6. Corporate governance
  7. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Analysts

Analysts

Mirabaud Securities Ltd
Olav Zilian, MD, PhD, EMBA

Laura Pfeiffer-Rossi
Octavian AG

NIBC Bank N.V.
Dylan van Haaften

LifeSci Capital
David Sherman, Ph.D.(AC)
REPORTS ENG DE
LifeSci Capital - Initiation Research